Skip to main content
Log in

In vitro activity of flomoxef in comparison to other cephalosporins

In vitro-Aktivität von Flomoxef im Vergleich zu anderen Cephalosporinen

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Flomoxef and cefazolin had nearly the same activity against staphylococci, which was stronger than that of other cephalosporins. AgainstStreptococcus pyogenes, Streptococcus agalactiae andStreptococcus pneumoniae, cefotaxime and cefazolin were more active than flomoxef, but the other cephamycins were less active than flomoxef. In comparison to the other cephalosporins, latamoxef and flomoxef had higher activity againstBranhamella catarrhalis, whereas cefotaxime, latamoxef and cefotetan were more active againstHaemophilus influenzae. Flomoxef was the only drug exhibiting activity againstClostridium difficile. The activity of flomoxef and latamoxef againstBacteroides fragilis was stronger than that of the other cephalosporins, butBacteroides bivius was resistant to each of these antibiotics.

Zusammenfassung

Flomoxef und Cefazolin hatten gegen Staphylokokken ungefähr die gleiche Wirksamkeit, während die anderen Cephalosporine schwächer wirkten. GegenStreptococcus pyogenes, Streptococcus agalactiae undStreptococcus pneumoniae waren Cefotaxim und Cefazolin stärker wirksam als Flomoxef, jedoch war Flomoxef den anderen Cephamycinen überlegen. Im Vergleich zu den anderen Cephalosporinen waren Latamoxef und Flomoxef stärker wirksam gegenBranhamella catarrhalis, während Cefotaxim, Latamoxef und Cefotetan gegenHaemophilus influenzae aktiver waren. Flomoxef war das einzig wirksame Mittel gegenClostridium difficile. GegenBacteroides fragilis wirkten Flomoxef und Latamoxef am besten (nurBacteroides bivius war völlig resistent).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature

  1. Tsuji, T., Satoh, M., Narisada, M., Hamashima, Y., Yoshida, T. Synthesis and antibacterial activity of 6315-S, a new member of the oxacephem antibiotic. J. Antibiot. 38 (1985) 466–476.

    Google Scholar 

  2. Suzuki, K., Takanashi, K. 6315-S (flomoxef) in urological infections. Chemotherapy 35 (1987) 1016–1031.

    Google Scholar 

  3. Kuriyama, M., Takahashi, Y. 6315-S (flomoxef), a newly synthesized oxacephem, in urology. Chemotherapy 35 (1987) 1032–1048.

    Google Scholar 

  4. Neu, H. C., Chin, N-X. In vitro activity and β-lactamase stability of a new difluoro oxacephem, 6315-S. Antimicrob. Agents Chemother. 30 (1986) 638–644.

    Google Scholar 

  5. Sagawa, T., Mure, K. 6315-S (flomoxef) in obstetrics and gynecology. Chemotherapy 30 (1987) 1164–1171.

    Google Scholar 

  6. Matsuda, S., Suzuki, M. 6315-S (flomoxef) in obstetrics and gynecology. Chemotherapy 35 (1987) 1189–1195.

    Google Scholar 

  7. Goto, T., Shimada, T. 6315-S (flomoxef) in urinary tract infections. Chemotherapy 35 (1987) 1130–1137.

    Google Scholar 

  8. Matsumoto, T., Kitada, S. Clinical experience with 6315-S (flomoxef) in urinary tract infection. Chemotherapy 35 (1987) 1102–1120.

    Google Scholar 

  9. Sakai, K., Fujimoto, M. A comparative study on the efficacy of 6315-S (flomoxef) and cefotiam. Chemotherapy 35 (1987) 912–942.

    Google Scholar 

  10. Werner, H. Inhibitory activity of cefotetan and other β-lactams against anaerobes. J. Antimicrob. Chemother. 11 (1983) 107–115.

    Google Scholar 

  11. Fujii, A., Nakanishi, T. 6315-S (flomoxef) in urinary tract infection. Chemotherapy 35 (1987) 1059–1069.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simon, C., Simon, M. & Plieth, C. In vitro activity of flomoxef in comparison to other cephalosporins. Infection 16, 131–134 (1988). https://doi.org/10.1007/BF01644322

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01644322

Keywords

Navigation